Sanofi (SNYNF) Total Debt (2009 - 2025)
Sanofi (SNYNF) posted Total Debt of $21.6 billion for Q4 2025, down 6.79% sequentially from $23.2 billion in Q2 2025, and up 26.57% YoY from $17.1 billion in Q4 2024.
Sanofi (SNYNF) Total Debt (2009 - 2025) Analysis & Trends
Sanofi (SNYNF) has 17 years of Total Debt data on file, last reported at $21.6 billion in Q4 2025.
- Quarterly Total Debt rose 26.57% year-over-year to $21.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.6 billion (up 26.57% YoY) and the FY2025 annual result came in at $21.6 billion, up 26.57% from the prior year.
- Total Debt declined to $21.6 billion in Q4 2025 per SNYNF's latest filing, from $23.2 billion in the prior quarter.
- The five-year high for Total Debt was $24.3 billion in Q2 2021, with the low at $17.1 billion in Q4 2024.
- Average Total Debt over 5 years is $21.1 billion, with a median of $21.1 billion recorded in 2023.
- Year-over-year, Total Debt slipped 16.47% in 2022 and climbed 26.57% in 2025.
- Sanofi's Total Debt stood at $23.2 billion in 2021, then declined by 16.42% to $19.4 billion in 2022, then slipped by 9.17% to $17.6 billion in 2023, then decreased by 3.06% to $17.1 billion in 2024, then advanced by 26.57% to $21.6 billion in 2025.
- Business Quant data shows SNYNF's Total Debt at $21.6 billion in Q4 2025, $23.2 billion in Q2 2025, and $17.1 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 43.37 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 54.99 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 64.53 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -24.45 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 49.12 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 57.32 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 22.17 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 64.46 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -19.00 Mn |
| 10 | Sanofi | - | - | 9.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.64 Bn |
| Jun 30, 2025 | 23.22 Bn |
| Dec 31, 2024 | 17.10 Bn |
| Jun 30, 2024 | 23.41 Bn |
| Dec 31, 2023 | 17.64 Bn |
| Jun 30, 2023 | 20.62 Bn |
| Dec 31, 2022 | 19.42 Bn |
| Jun 30, 2022 | 20.28 Bn |
| Dec 31, 2021 | 23.23 Bn |
| Jun 30, 2021 | 24.28 Bn |
| Dec 31, 2020 | 26.84 Bn |
| Jun 30, 2020 | 26.14 Bn |
| Dec 31, 2019 | 27.32 Bn |
| Jun 30, 2019 | 28.65 Bn |
| Dec 31, 2018 | 28.12 Bn |
| Dec 31, 2017 | 18.37 Bn |
| Jun 30, 2017 | 20.26 Bn |
| Dec 31, 2016 | 20.06 Bn |
| Jun 30, 2016 | 16.95 Mn |
| Dec 31, 2015 | 18.15 Bn |